 The stock price of United Therapeutics, a biotechnology company, has seen a rise of over 15 over the last twenty-one trading days, and it is up a solid 97 over the last twelve-month period. The rally in UTHR stock over the last month or so has been propelled by its very strong and upbeat Q2. 